This is the authors' abstract. We don't add key points for this paper.
The development of a telescoped process for the API step in the route to a reversible inhibitor of BTK is reported. Although a robust and effective reaction and crystallization was previously implemented, concerns around the storage and stability of the penultimate material led to investigating a telescoped process. Utilizing design of experiments (DoE) to understand impacts to the API reaction and high-throughput extractions (HTEx) to optimize the workup, a process was rapidly developed to achieve the same quality API with an overall 13% improvement to yield and 41% improvement in the process mass intensity (PMI).
No takes yet. Share an insight, caveat, or question.
Gonzalez et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: